130 related articles for article (PubMed ID: 707104)
1. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection.
Schiøtz PO; Nielsen H; Høiby N; Glikmann G; Svehag SE
Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):37-40. PubMed ID: 707104
[TBL] [Abstract][Full Text] [Related]
2. Activated complement in the sputum from patients with cystic fibrosis.
Schiøtz PO; Sørensen H; Høiby M
Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
4. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes in cystic fibrosis.
Schiotz PO; Hoiby N; Juhl F; Permin H; Nielsen H; Svehag SE
Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):57-64. PubMed ID: 300210
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
8. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment.
Schiøtz PO; Jørgensen M; Flensborg EW; Faerø O; Husby S; Høiby N; Jacobsen SV; Nielsen H; Svehag SE
Acta Paediatr Scand; 1983 Mar; 72(2):283-7. PubMed ID: 6340415
[TBL] [Abstract][Full Text] [Related]
9. Platelet 3H-serotonin releasing immune complexes induced by Pseudomonas aeruginosa in cystic fibrosis.
Permin H; Skov PS; Norn S; Høiby N; Schiøtz PO
Allergy; 1982 Feb; 37(2):93-100. PubMed ID: 7137525
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
Hoiby N; Flensborg EW; Beck B; Friis B; Jacobsen SV; Jacobsen L
Scand J Respir Dis; 1977 Apr; 58(2):65-79. PubMed ID: 404701
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Holby N; Olling S
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases.
Schiøtz PO; Clemmensen I; Høiby N
Acta Pathol Microbiol Scand C; 1980 Oct; 88(5):275-80. PubMed ID: 7008501
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
Doggett RG; Harrison GM
Infect Immun; 1972 Oct; 6(4):628-35. PubMed ID: 4628901
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.
Johansen HK; Nørregaard L; Gøtzsche PC; Pressler T; Koch C; Høiby N
Pediatr Pulmonol; 2004 May; 37(5):427-32. PubMed ID: 15095326
[TBL] [Abstract][Full Text] [Related]
17. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
Holby N
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
[TBL] [Abstract][Full Text] [Related]
19. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.
Cowan RG; Winnie GB
J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
